Falsified Medicines Directive (FMD): how it will work The Falsified Medicines Directive will be rolled out in Europe from February 2019 to address the threat of fake medicines and will impact the entire supply chain…
New dispensing error decriminalisation legislation due by April 2018 New legislation to protect community pharmacists from prosecution over dispensing errors has been signed into law by the Privy Council.…
Oxford University Hospitals to pilot Falsified Medicines Directive process Oxford University Hospitals NHS Foundation Trust is to pilot a system for compliance with the Falsified Medicines Directive.…
FMD guidance for community pharmacists Guidance published to help community pharmacists implement the requirements of the European Union Falsified Medicines Directive…
Five pharmacists suspended as MHRA ups investigations into NHS drugs appearing on black market Organised criminal gangs are diverting drugs from the NHS supply chain and selling them on the black market in an illegal racket estimated to be worth up to £200m…
EMA recommends seven new medicines for approval Included in the recommendations by the Committee for Medicinal Products for Human Use were one biosimilar and one orphan medicine…
Moving from retail to industry: a letter to all pharmacists Former community pharmacist Vikesh Lad describes his new career at the Medicines and Healthcare products Regulatory Agency.…
FDA to take new approach on homeopathic products The US Food and Drug Administration is to introduce a new ‘risk-based enforcement approach’ to drug products that are labeled ‘homeopathic’ and available on the American market.…
EMA recommends seven new medicines for approval across the EU Seven new medicines are being recommended for approval for use across the European Union following a meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use.…
Patient organisations call for faster access to orphan drugs Faster access to medicines for rare diseases across Europe will help reinforce European competitiveness in the global medicines marketplace, a rare disease patient organisation has said…